Sanofi-aventis Deutschland Gmbh
Overview
Sanofi-aventis Deutschland Gmbh is a pharmaceutical company headquartered in Frankfurt, Germany, founded in 2004, with 5,001-10,000 employees.
Active pharmaceutical ingredients supplied
Substances Sanofi-aventis Deutschland Gmbh is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Sanofi-aventis Deutschland Gmbh holds 0 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- PREDNICARBATEInactive2011-06-02
- FEXOFENADINE HYDROCHLORIDE (MDL 16455 A)Inactive2009-12-10
- ARTICAINE HYDROCHLORIDEInactive2006-12-19
- CICLOPIROX OLAMINEInactive1999-12-17
- HR1799 - RECOMBINANT HUMAN INSULINInactive1999-01-15
- HUMAN INSULIN-SEMISYNTHETIC, BULK MATRLS & FINISHED DOS. FORMInactive1983-03-11
- D-PROPOXYPHENE HYDROCHLORIDE BULKInactive1972-07-24
FDA compliance signals
5 FDA enforcement records linked to this company.
- 4832017-03-03
Establish reliability of supplier's C of A
- 4832017-03-03
Written record of investigation incomplete
- 4832017-03-03
Equipment to control conditions
- 4832017-03-03
Validation lacking for sterile drug products
- warning_letter2011-02-08
FDA Warning Letter (drug product)
Is this Sanofi-aventis Deutschland Gmbh? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.